---
figid: PMC4148348__nihms612517f2
figtitle: Orteronel for the treatment of prostate cancer
organisms:
- NA
pmcid: PMC4148348
filename: nihms612517f2.jpg
figlink: /pmc/articles/PMC4148348/figure/F2/
number: F2
caption: 'The dashed line indicates potent inhibition by orteronel and the dotted
  line indicates weaker inhibition by orteronel. AR: Androgen receptor; DHEA: Dehydroepiandrosterone;
  DHT: Dihydrotestosterone.'
papertitle: Orteronel for the treatment of prostate cancer.
reftext: Kathryn Van Hook, et al. Future Oncol. ;10(5):803-811.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9469469
figid_alias: PMC4148348__F2
figtype: Figure
organisms_ner:
- NA
redirect_from: /figures/PMC4148348__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4148348__nihms612517f2.html
  '@type': Dataset
  description: 'The dashed line indicates potent inhibition by orteronel and the dotted
    line indicates weaker inhibition by orteronel. AR: Androgen receptor; DHEA: Dehydroepiandrosterone;
    DHT: Dihydrotestosterone.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Androstenedione
  - Cholesterol
  - 11-deoxycortisol
  - DHEA
  - Cortisol
  - 17a-hydroxypregnenolone
  - Pregnenolone
  - Progesterone
  - Testosterone
---
